Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Semaphorin 3C (Sema3C) inhibitor therapeutics, methods, and uses

Semaphorin 3C (Sema3C) inhibitor therapeutics, methods, and uses

US Patent 8808693 · Granted Aug 19, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

B1SP fusion protein therapeutics, methods, and uses2025
B1SP fusion protein therapeutics, methods, and uses2025
B1SP fusion protein therapeutics, methods, and uses2025
Mucoadhesive polymeric drug delivery compositions and methods2024
Polymeric paste compositions for drug delivery2021
B1SP fusion protein therapeutics, methods, and uses2021
B1SP fusion protein therapeutics, methods, and uses2021
B1SP fusion protein therapeutics, methods, and uses2021
Derivatized hyperbranched polyglycerols2020
Derivatized hyperbranched polyglycerols2018
Dual targeting antisense oligonucleotides as apoptotic inhibtor therapeutic comp2017
Combination therapy for cancer using HSP27 inhibitor and EGFR tyrosine kinase in2017